Found 0 matching trials
A PoC Study to Evaluate Treatments' Efficacy by Monitoring MRD Using ctDNA in HR-positive/HER2-negative EBC Population PHASE2 This trial is a multicenter, open-label, non-comparative, phase II, biomark...
Show More Location
Complejo Hospitalario Universitario A Coruña (CHUAC)
Learn More & Join Trial
CIrCuLAting Dna ESr1 Gene Mutations Analysis NA The estrogen-dependent nature of breast cancer was first reported in 1896 w...
Show More Location
Hôpital Claude Bernard
Learn More & Join Trial
Study Assessing the Efficacy and Safety of Treatment With Alpelisib Plus Fulvestrant Versus Placebo Plus Fulvestrant in Chinese Men and Postmenopausal Women With Advanced Breast Cancer PHASE2 The primary objective is to evaluate whether treatment with alpelisib in co...
Show More Status
Active Not Recruiting
Location
Novartis Investigative Site
Learn More & Join Trial
Copanlisib in Treating Patients With Persistent or Recurrent Endometrial Cancer PHASE2 This phase II trial studies how well copanlisib works in treating patients ...
Show More Learn More & Join Trial
Molecular Phenotype Changes and Personalized Treatment for CRPC NA To explore the molecular phenotypic changes and personalized treatment in c...
Show More Location
Department of Interventional Oncology, Tianjin Medical University Cancer Institute and Hospital
Learn More & Join Trial
Akt Inhibitor MK2206 in Treating Patients With Previously Treated Colon or Rectal Cancer That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery PHASE2 This phase II trial studies how well v-akt murine thymoma viral oncogene ho...
Show More Location
M D Anderson Cancer Center
Learn More & Join Trial
PIK3CA in HER2+ BC and pCR Trial NA The goal of the study is to evaluate the impact of somatic PI3KCA mutations...
Show More Location
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Learn More & Join Trial
Biomarkers in Tissue Samples From Older Women With Breast Cancer N/A This research trial studies phosphatidylinositol-4,5-bisphosphate 3-kinase,...
Show More Location
Multiple Locations
Learn More & Join Trial
Akt Inhibitor MK-2206 and Anastrozole With or Without Goserelin Acetate in Treating Patients With Stage II-III Breast Cancer PHASE2 This phase II trial studies how well Akt inhibitor MK-2206 (MK-2206) and an...
Show More Location
Mayo Clinic in Arizona
Learn More & Join Trial
Studying Tissue Samples From Patients With Stage II Colon Cancer Treated on Clinical Trial CLB-9581 N/A This research trial studies tissue samples from patients with stage II colo...
Show More Location
Brigham and Women's Hospital
Learn More & Join Trial